Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma
Lin Xiao(UNSW Sydney), Michelle Haber(Cancer Institute of New South Wales)
Cited by 31
Related Papers
The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression
|Frontiers in Oncology|2022|13
Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma
|Journal of Experimental & Clinical Cancer Research|2025|1